Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors (Q39928704)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 November 2009
edit
Language Label Description Also known as
English
Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors
scientific article published on 16 November 2009

    Statements

    Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors (English)
    Richard T Penson
    Don S Dizon
    Stephen A Cannistra
    Maria R Roche
    Carolyn N Krasner
    Suzanne T Berlin
    Neil S Horowitz
    Paul A Disilvestro
    Hang Lee
    Modjulie A King
    Susana M Campos
    16 November 2009
    154-159

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit